Pacific released a research report on April 24 stating that Baiya shares (003006.SZ) were given a purchase rating. The main reasons for the rating include: 1) the structural drive profit of major health products such as probiotics; 2) high marketing investment continues to be realized in e-commerce and peripherals. (Mainichi Keizai Shimbun)
太平洋4月24日发布研报称，给予百亚股份（003006.SZ）买入评级。评级理由主要包括：1）益生菌等大健康产品结构性驱增盈利；2）高营销投入在电商和外围持续兑现。（每日经济新闻）
Pacific released a research report on April 24 stating that Baiya shares (003006.SZ) were given a purchase rating. The main reasons for the rating include: 1) the structural drive profit of major health products such as probiotics; 2) high marketing inves
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.